发明名称 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COLORECTAL CANCERS OR INHIBITION OF METASTASIS CONTAINING THE EXPRESSION OR ACTIVITY INHIBITORS OF CARBONYL REDUCTASE 1
摘要 In the present invention, it has been first established that CBR1 functions as a colorectal cancer growth and metastasis inducing factor and has been confirmed that CBR 1 is overexpressed in the colorectal cancer cell line; and as a result of inhibiting CBR1 expression in the colorectal cancer cell line, cell growth, cancer cell invasion, cell mobility, and substrate attachment are reduced and cell signaling associated with FAK/c-Src is also reduced. Therefore, a material to inhibit the expression or activation of CBR 1 can be used to prevent and treat colorectal cancer.
申请公布号 KR20140072624(A) 申请公布日期 2014.06.13
申请号 KR20120140350 申请日期 2012.12.05
申请人 KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY 发明人 KIM, SE MI;LEE, YUN HEE
分类号 A61K38/16;A61K31/7105;A61K38/17;A61K48/00 主分类号 A61K38/16
代理机构 代理人
主权项
地址